Elicera Therapeutics AB Financial Flexibility Index
Elicera Therapeutics AB financial flexibility index. Elicera Therapeutics AB (ELIC) has a Financial Flexibility Index of -0.68x as of September 2025. Free cash flow of Skr-4.74 Million (operating CF Skr-4.74 Million minus capex Skr0.00) represents -1% of total liabilities (Skr6.97 Million). See Elicera Therapeutics AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Elicera Therapeutics AB (2017–2024)
Financial flexibility index of Elicera Therapeutics AB from 2017 to 2024. Historical Financial Flexibility Index trend for Elicera Therapeutics AB across 8 annual periods. Check ELIC cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Elicera Therapeutics AB Financial Flexibility Index by Year (2017–2024)
Elicera Therapeutics AB financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Elicera Therapeutics AB. For the full cash flow conversion analysis, see Elicera Therapeutics AB cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.45x | Skr-23.46 Million | Skr-23.46 Million | Skr6.79 Million | ▼ -219.0% |
| 2023 | -1.08x | Skr-14.92 Million | Skr-14.92 Million | Skr13.78 Million | ▼ -70.7% |
| 2022 | -0.63x | Skr-8.57 Million | Skr-8.57 Million | Skr13.51 Million | ▲ +88.9% |
| 2021 | -5.72x | Skr-14.29 Million | Skr-14.29 Million | Skr2.50 Million | ▼ -1489.8% |
| 2020 | -0.36x | Skr-846.37K | Skr-905.25K | Skr2.35 Million | ▲ +99.4% |
| 2019 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | ▲ +0.0% |
| 2018 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | ▲ +0.0% |
| 2017 | -59.79x | Skr-239.16K | Skr-239.16K | Skr4.00K | — |